組織工程市場規模、佔有率、成長分析、按產品、按材料、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球組織工程市場規模為37.5億美元，從2023年的44.2億美元成長到2031年的137.4億美元，預測期（2024-2031）預計複合年成長率為15.23%。

組織工程市場正在迅速發展，以滿足器官移植和組織再生的關鍵需求。傳統的移植方法面臨器官短缺和排斥等問題，增加了創新解決方案的需求。組織工程已成為一種可行的替代方案，並有望透過提供根據患者個體需求量身定做的生物工程組織和器官來改變各種疾病和損傷的治療格局。包括心血管疾病和器官衰竭在內的慢性疾病的日益流行，成為市場成長的關鍵催化劑，因為組織工程提供了潛在的再生解決方案。然而，這個市場面臨著巨大的投資需求的挑戰，包括昂貴的實驗室設備、研究材料和大規模臨床試驗，以及阻礙開發和核准過程的監管障礙。儘管存在這些障礙，幹細胞研究和技術創新的進步為市場擴張提供了堅實的基礎。未來的商機在於個人化醫療和再生醫學領域，它們不僅有可能顯著改善患者的治療，而且有可能改變整個醫療保健領域。隨著組織工程市場不斷成熟，解決高開發成本和創新解決方案之間的平衡對於充分發揮其潛力至關重要。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價格分析
• 價值鏈分析
• 供應鏈分析
• 技術分析
• 專利分析
• 監管環境
• 客戶和購買標準分析

組織工程市場：依產品

• 市場概況
• 鷹架
  • 合成支架
  • 生物支架
  • 膠原蛋白蛋白支架
  • 水凝膠支架
  • 基於幹細胞的支架
  • 其他基於生物材料的支架
• 組織移植
  • 同種異體移植
  • 自體移植
  • 合成移植物
  • 異種移植
• 其他產品

組織工程市場：依材料分類

• 市場概況
• 合成材料
• 生物來源材料

組織工程市場：依應用分類

• 市場概況
• 整形外科和肌肉骨骼疾病
• 皮膚科/創傷護理
• 牙科疾病
• 心血管疾病
• 其他用途

組織工程市場：依最終使用者分類

• 市場概況
• 醫院
• 專科中心和診所
• 門診手術中心

組織工程市場規模：依地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Organogenesis Inc.
• AbbVie Inc.
• MiMedx Group, Inc.
• Johnson & Johnson Services, Inc.
• B. Braun SE
• NuVasive, Inc.
• WL Gore & Associates, Inc.
• Zimmer Biomet
• Collplant Biotechnologies Ltd.
• Sumitomo Pharma Co., Ltd.
• Regrow Biosciences Pvt. Ltd.
• Tecnoss SRL
• Integra Lifesciences
• Smith & Nephew Plc
• Baxter
• BD
• Teijin Limited
• Institut Straumann Ag
• Medtronic
• Stryker
• Terumo Corporation
• Zimmer Biomet
• TissueTech
• Matricel Gmbh
• Mallinckrodt
• Vericel Corporation
• Tegoscience
• Tissue Regenix

Global Tissue Engineering Market size was valued at USD 3.75 billion in 2022 and is poised to grow from USD 4.42 billion in 2023 to USD 13.74 billion by 2031, growing at a CAGR of 15.23% during the forecast period (2024-2031).

The tissue engineering market is rapidly evolving to meet the critical demand for organ transplantation and tissue regeneration. Traditional transplantation methods struggle with issues such as organ shortages and rejection, which has intensified the need for innovative solutions. Tissue engineering emerges as a viable alternative, offering customized bioengineered tissues and organs tailored to individual patient requirements, thus holding the promise to transform the treatment landscape for various diseases and injuries. The increasing prevalence of chronic diseases, including cardiovascular disorders and organ failures, serves as a key catalyst for market growth, as tissue engineering provides potential regenerative solutions. However, the market faces challenges due to substantial investment needs, including costly laboratory equipment, research materials, and extensive clinical trials, alongside regulatory hurdles that can impede development and approval processes. Despite these obstacles, advancements in stem cell research and technological innovations create a robust foundation for market expansion. Future opportunities lie in the realms of personalized and regenerative medicine therapies, which not only offer the potential to enhance patient care significantly but also revolutionize healthcare practices overall. As the tissue engineering market continues to mature, addressing the balance between high development costs and innovative solutions will be crucial for unlocking its full potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Engineering market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Engineering Market Segmental Analysis

Global Tissue Engineering Market is segmented by Product, Material, Application, End User, and Region. Based on Product, the market is segmented into Scaffolds (Synthetic Scaffolds, Biological Scaffolds (Collagen-Based Scaffolds, Hydrogel-Based Scaffolds, Stem Cell-Based Scaffolds, Other Biological Material-Based Scaffolds)), Tissue Grafts (Allografts, Autografts, Synthetic Grafts, Xenografts), Other Products. Based on Material, the market is segmented into Synthetic Materials, Biologically Derived Materials. Based on Application, the market is segmented into Orthopedic & Musculoskeletal Disorders, Dermatology & Wound Care, Dental Disorders, Cardiovascular Diseases, Other Applications. Based on End User, the market is segmented into Hospitals, Specialty Centers & Clinics, Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Engineering Market

The rising incidence of chronic diseases, including cardiovascular disorders, orthopedic conditions, and organ failures, significantly drives the global tissue engineering market. As the prevalence of these ailments increases, there is a growing demand for innovative therapeutic solutions that tissue engineering offers, such as the development and regeneration of tissues and organs. This field provides advanced treatment options, enhancing patient outcomes and addressing the limitations of traditional therapies. Consequently, healthcare providers and researchers are increasingly investing in tissue engineering technologies, which is catalyzing market growth and fostering innovations that aim to meet the urgent clinical needs of an aging population beset by chronic conditions.

Restraints in the Global Tissue Engineering Market

The global tissue engineering market encounters significant market restraints primarily due to stringent regulatory challenges that revolve around safety, efficacy, and ethical concerns associated with bioengineered tissues and cells. These regulations require extensive preclinical and clinical testing to ensure that products meet safety standards, which can lead to protracted approval timelines. Consequently, this not only hampers innovation and the introduction of novel therapies but also restricts the accessibility of existing tissue engineering solutions, as companies grapple with compliance costs and delays. Such regulatory hurdles ultimately inhibit market growth and deter investments, curtailing the proliferation of advanced tissue engineering technologies.

Market Trends of the Global Tissue Engineering Market

The Global Tissue Engineering market is witnessing a significant shift towards personalized medicine, driven by the increasing demand for customized healthcare solutions. As advancements in tissue engineering technology enable the creation of tailored tissues and organs that align with individual patient specifications, this trend is leading to enhanced treatment effectiveness and reduced rejection rates. The integration of precision medicine principles fosters a patient-centric approach, further bolstering market growth. As healthcare systems increasingly adopt personalized strategies, the tissue engineering sector is poised for innovation and expansion, reaffirming its critical role in addressing diverse patient needs and improving overall outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Technology Analysis
• Patent Analysis
• Regulatory Landscape
• Customer & Buying Criteria Analysis

Tissue Engineering Market, By Product

• Market Overview
• Scaffolds
  • Synthetic Scaffolds
  • Biological Scaffolds
  • Collagen-Based Scaffolds
  • Hydrogel-Based Scaffolds
  • Stem Cell-Based Scaffolds
  • Other Biological Material-Based Scaffolds
• Tissue Grafts
  • Allografts
  • Autografts
  • Synthetic Grafts
  • Xenografts
• Other Products

Tissue Engineering Market, By Material

• Market Overview
• Synthetic Materials
• Biologically Derived Materials

Tissue Engineering Market, By Application

• Market Overview
• Orthopedic & Musculoskeletal Disorders
• Dermatology & Wound Care
• Dental Disorders
• Cardiovascular Diseases
• Other Applications

Tissue Engineering Market, By End User

• Market Overview
• Hospitals
• Specialty Centers & Clinics
• Ambulatory Surgery Centers

Tissue Engineering Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Organogenesis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiMedx Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collplant Biotechnologies Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Pharma Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regrow Biosciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecnoss S.R.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teijin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Institut Straumann Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TissueTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matricel Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tegoscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments